McNamara Robert
SEC insider (Form 3/4/5 filer). CIK 0001387652. Director at AVITA Medical, Inc. (RCEL) and 1 other issuer. 7 reported Form 4/5 transactions since Sep 2024; latest on Jan 20, 2026. Located in VALENCIA, CA.
Companies McNamara Robert has filed insider reports for
- AVITA Medical, Inc. (RCEL): Director
- Axonics, Inc. (AXNX): Director
McNamara Robert
CIK: 0001387652
Transaction Breakdown
Open Market Buys (P)4 (57.1%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (28.6%)
Compensation grants
Other (G, F, J, C, D, …)1 (14.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jan 20, 2026RCEL
AVITA Medical, Inc.
AwardDirect22.2K shares- - Aug 28, 2025RCEL
AVITA Medical, Inc.
PurchaseDirect10K shares at avg. $4.50$45K - Aug 19, 2025RCEL
AVITA Medical, Inc.
PurchaseDirect10K shares at avg. $5.00$50K - Mar 6, 2025RCEL
AVITA Medical, Inc.
PurchaseDirect11K shares at avg. $8.30$91K - Feb 20, 2025RCEL
AVITA Medical, Inc.
PurchaseDirect10K shares at avg. $10.09$101K - Jan 21, 2025RCEL
AVITA Medical, Inc.
AwardDirect10K shares- - Nov 15, 2024AXNX
Axonics, Inc.
DispositionDirect14.9K shares at avg. $71.00$1.1M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 20, 2026 |  RCEL AVITA Medical, Inc. | Award | 22,214 | - | $0 | Direct |
| Aug 28, 2025 | RCEL AVITA Medical, Inc. | Purchase | 10,000 | $4.50 | $45,000 | Direct |
| Aug 19, 2025 | RCEL AVITA Medical, Inc. | Purchase | 10,000 | $5.00 | $50,000 | Direct |
| Mar 6, 2025 | RCEL AVITA Medical, Inc. | Purchase | 11,000 | $8.30 | $91,300 | Direct |
| Feb 20, 2025 | RCEL AVITA Medical, Inc. | Purchase | 10,000 | $10.09 | $100,900 | Direct |
| Jan 21, 2025 | RCEL AVITA Medical, Inc. | Award | 10,022 | - | - | Direct |
| Nov 15, 2024 |  AXNX Axonics, Inc. | Disposition | 14,861 | $71.00 | $1,055,131 | Direct |
1-7 of 7 transactions